newsfilter
← Latest News
Business Wire·

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders

Believes Company's Misguided Acquisition Strategy is Destroying Value and Preventing Dynavax from Maximizing the Opportunities of Heplisav for Shareholders and Patients In Deep Track's View, Properly Focusing on